Article Details
Retrieved on: 2023-12-04 17:24:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jaypirca, which was first approved earlier this year, can now be used to treat chronic lymphocytic leukemia and small lymphocytic lymphoma.
Article found on: www.biopharmadive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here